Neural Regeneration Research, 2017 · DOI: 10.4103/1673-5374.205106 · Published: April 1, 2017
This study investigates how Mitomycin C (MMC), a drug known to reduce scarring, affects cells called fibroblasts that contribute to scar formation after spinal cord surgery. The researchers found that MMC can trigger a process called apoptosis (cell death) in these fibroblasts, potentially explaining how it reduces scar tissue. Further investigation revealed that this apoptosis involves a specific cellular stress pathway, the endoplasmic reticulum stress pathway, suggesting a target for further therapeutic interventions.
Mitomycin C has potential as a therapeutic agent for preventing excessive postoperative scarring after surgical decompression in spinal cord injury patients.
The endoplasmic reticulum stress pathway may be a target for future therapeutic interventions aimed at reducing epidural fibrosis.
Further research is needed to fully clarify the intracellular signal transduction mechanisms involved in MMC-induced apoptosis of HESFs.